お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
973463

ゲノム編集の世界市場:2020年~2024年

Global Genome Editing Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
ゲノム編集の世界市場:2020年~2024年
出版日: 2020年11月12日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のゲノム編集の市場規模は、2020年から2024年の間に48億米ドル成長し、予測期間中は17%のCAGRで成長する見込みです。

市場は、ゲノム編集アプリケーションの増加と遺伝子組み換え作物の需要増加によって推進されています。

当レポートでは、ゲノム編集の世界市場を調査し、市場情勢や規模、ファイブフォース分析、エンドユーザー別の市場セグメンテーション、顧客や地域別情勢、ベンダー情勢、ベンダー分析などの情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション
  • エンドユーザー別比較
  • 製薬・バイオテクノロジー企業:市場規模と予測(2019年~2024年)
  • 学術・研究機関:市場規模と予測(2019年~2024年)
  • CRO(開発業務受託機関):市場規模と予測(2019年~2024年)
  • エンドユーザー別市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2019年~2024年)
  • 欧州:市場規模と予測(2019年~2024年)
  • アジア:市場規模と予測(2019年~2024年)
  • その他の地域:市場規模と予測(2019年~2024年)
  • 主要国
  • 地域別の市場機会
  • 市場の推進力
  • 市場の課題
  • 市場動向

ベンダー情勢

  • ベンダー情勢
  • 創造的破壊の状況
  • 競合シナリオ

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Eurofins Scientific SE
  • GenScript Biotech Corp.
  • Horizon Discovery Group Plc
  • Integrated DNA Technologies Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Precision BioSciences Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR45678

Technavio has been monitoring the genome editing market and it is poised to grow by $ 4.8 bn during 2020-2024, progressing at a CAGR of 17% during the forecast period. Our reports on genome editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing applications of genome editing and the increasing demand for genetically edited crops. In addition, increasing applications of genome editing is anticipated to boost the growth of the market as well.

The genome editing market analysis includes the end-user segment and geographical landscapes.

Technavio's genome editing market is segmented as below:

By End-user

  • Pharmaceutical and biotechnology companies
  • Academic institute and research laboratories
  • CROs

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies an increase in human genomics research as one of the prime reasons driving the genome editing market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our genome editing market covers the following areas:

  • Genome editing market sizing
  • Genome editing market forecast
  • Genome editing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genome editing market vendors that include Eurofins Scientific SE, GenScript Biotech Corp., Horizon Discovery Group Plc, Integrated DNA Technologies Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Precision BioSciences Inc., Sangamo Therapeutics Inc., and Thermo Fisher Scientific Inc. Also, the genome editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
  • Academic institute and research laboratories - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • Market opportunity by End-user

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Eurofins Scientific SE
  • GenScript Biotech Corp.
  • Horizon Discovery Group Plc
  • Integrated DNA Technologies Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • Precision BioSciences Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: End user - Market share 2019-2024 (%)
  • 22: Comparison by End user
  • 23: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
  • 24: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
  • 25: Academic institute and research laboratories - Market size and forecast 2019-2024 ($ million)
  • 26: Academic institute and research laboratories - Year-over-year growth 2019-2024 (%)
  • 27: CROs - Market size and forecast 2019-2024 ($ million)
  • 28: CROs - Year-over-year growth 2019-2024 (%)
  • 29: Market opportunity by End user
  • 30: Customer landscape
  • 31: Market share by geography 2019-2024 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: Europe - Market size and forecast 2019-2024 ($ million)
  • 36: Europe - Year-over-year growth 2019-2024 (%)
  • 37: Asia - Market size and forecast 2019-2024 ($ million)
  • 38: Asia - Year-over-year growth 2019-2024 (%)
  • 39: ROW - Market size and forecast 2019-2024 ($ million)
  • 40: ROW - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Eurofins Scientific SE - Overview
  • 50: Eurofins Scientific SE - Business segments
  • 51: Eurofins Scientific SE - Key offerings
  • 52: Eurofins Scientific SE - Key customers
  • 53: Eurofins Scientific SE - Segment focus
  • 54: GenScript Biotech Corp. - Overview
  • 55: GenScript Biotech Corp. - Business segments
  • 56: GenScript Biotech Corp. - Key offerings
  • 57: GenScript Biotech Corp. - Key customers
  • 58: GenScript Biotech Corp. - Segment focus
  • 59: Horizon Discovery Group Plc - Overview
  • 60: Horizon Discovery Group Plc - Business segments
  • 61: Horizon Discovery Group Plc - Key offerings
  • 62: Horizon Discovery Group Plc - Key customers
  • 63: Horizon Discovery Group Plc - Segment focus
  • 64: Integrated DNA Technologies Inc. - Overview
  • 65: Integrated DNA Technologies Inc. - Product and service
  • 66: Integrated DNA Technologies Inc. - Key offerings
  • 67: Integrated DNA Technologies Inc. - Key customers
  • 68: Integrated DNA Technologies Inc. - Segment focus
  • 69: Lonza Group Ltd. - Overview
  • 70: Lonza Group Ltd. - Business segments
  • 71: Lonza Group Ltd. - Key offerings
  • 72: Lonza Group Ltd. - Key customers
  • 73: Lonza Group Ltd. - Segment focus
  • 74: Merck KGaA - Overview
  • 75: Merck KGaA - Business segments
  • 76: Merck KGaA - Key offerings
  • 77: Merck KGaA - Key customers
  • 78: Merck KGaA - Segment focus
  • 79: New England Biolabs Inc. - Overview
  • 80: New England Biolabs Inc. - Product and service
  • 81: New England Biolabs Inc. - Key offerings
  • 82: New England Biolabs Inc. - Key customers
  • 83: New England Biolabs Inc. - Segment focus
  • 84: Precision BioSciences Inc. - Overview
  • 85: Precision BioSciences Inc. - Business segments
  • 86: Precision BioSciences Inc. - Key offerings
  • 87: Precision BioSciences Inc. - Key customers
  • 88: Precision BioSciences Inc. - Segment focus
  • 89: Sangamo Therapeutics Inc. - Overview
  • 90: Sangamo Therapeutics Inc. - Product and service
  • 91: Sangamo Therapeutics Inc. - Key offerings
  • 92: Sangamo Therapeutics Inc. - Key customers
  • 93: Sangamo Therapeutics Inc. - Segment focus
  • 94: Thermo Fisher Scientific Inc. - Overview
  • 95: Thermo Fisher Scientific Inc. - Business segments
  • 96: Thermo Fisher Scientific Inc. - Key offerings
  • 97: Thermo Fisher Scientific Inc. - Key customers
  • 98: Thermo Fisher Scientific Inc. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.